This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedman, S. M.
Right arrow Articles by Drlica, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedman, S. M.
Right arrow Articles by Drlica, K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2001, p. 2378-2380, Vol. 45, No. 8
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.8.2378-2380.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Mutation in the DNA Gyrase A Gene of Escherichia coli That Expands the Quinolone Resistance-Determining Region

S. Marvin Friedman,1,* Tao Lu,2 and Karl Drlica2

Department of Biological Sciences, Hunter College of The City University of New York, New York, New York 10021,1 and Public Health Research Institute, New York, New York 100162

Received 25 January 2001/Returned for modification 13 March 2001/Accepted 2 May 2001

In three Escherichia coli mutants, a change (Ala-51 to Val) in the gyrase A protein outside the standard quinolone resistance-determining region (QRDR) lowered the level of quinolone susceptibility more than changes at amino acids 67, 82, 84, and 106 did. Revision of the QRDR to include amino acid 51 is indicated.


* Corresponding author. Mailing Address: Department of Biological Sciences, Hunter College of The City University of New York, 695 Park Ave., New York, N.Y. 10021. Phone: (212) 772-5608. Fax: (212) 772-5227. E-mail: friedman{at}genectr.hunter.cuny.edu.


Antimicrobial Agents and Chemotherapy, August 2001, p. 2378-2380, Vol. 45, No. 8
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.8.2378-2380.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Spigaglia, P., Barbanti, F., Louie, T., Barbut, F., Mastrantonio, P. (2009). Molecular Analysis of the gyrA and gyrB Quinolone Resistance-Determining Regions of Fluoroquinolone-Resistant Clostridium difficile Mutants Selected In Vitro. Antimicrob. Agents Chemother. 53: 2463-2468 [Abstract] [Full Text]  
  • Black, M. T., Stachyra, T., Platel, D., Girard, A.-M., Claudon, M., Bruneau, J.-M., Miossec, C. (2008). Mechanism of Action of the Antibiotic NXL101, a Novel Nonfluoroquinolone Inhibitor of Bacterial Type II Topoisomerases. Antimicrob. Agents Chemother. 52: 3339-3349 [Abstract] [Full Text]  
  • Spigaglia, P., Barbanti, F., Mastrantonio, P., Brazier, J. S., Barbut, F., Delmee, M., Kuijper, E., R. Poxton, I., on behalf of the European Study Group on Clostridi, (2008). Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. J Med Microbiol 57: 784-789 [Abstract] [Full Text]  
  • Ostrov, D. A., Hernandez Prada, J. A., Corsino, P. E., Finton, K. A., Le, N., Rowe, T. C. (2007). Discovery of Novel DNA Gyrase Inhibitors by High-Throughput Virtual Screening. Antimicrob. Agents Chemother. 51: 3688-3698 [Abstract] [Full Text]  
  • Malik, M., Hussain, S., Drlica, K. (2007). Effect of Anaerobic Growth on Quinolone Lethality with Escherichia coli. Antimicrob. Agents Chemother. 51: 28-34 [Abstract] [Full Text]  
  • Huang, Y.-Y., Deng, J.-Y., Gu, J., Zhang, Z.-P., Maxwell, A., Bi, L.-J., Chen, Y.-Y., Zhou, Y.-F., Yu, Z.-N., Zhang, X.-E. (2006). The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA). Nucleic Acids Res 34: 5650-5659 [Abstract] [Full Text]  
  • Ellington, M. J., Woodford, N. (2006). Fluoroquinolone resistance and plasmid addiction systems: self-imposed selection pressure?. J Antimicrob Chemother 57: 1026-1029 [Abstract] [Full Text]  
  • Schmitz, G. E., Downs, D. M. (2006). An Allele of gyrA Prevents Salmonella enterica Serovar Typhimurium from Using Succinate as a Carbon Source.. J. Bacteriol. 188: 3126-3129 [Abstract] [Full Text]  
  • Valdezate, S., Vindel, A., Saez-Nieto, J. A., Baquero, F., Canton, R. (2005). Preservation of topoisomerase genetic sequences during in vivo and in vitro development of high-level resistance to ciprofloxacin in isogenic Stenotrophomonas maltophilia strains. J Antimicrob Chemother 56: 220-223 [Abstract] [Full Text]  
  • Lindgren, P. K., Marcusson, L. L., Sandvang, D., Frimodt-Moller, N., Hughes, D. (2005). Biological Cost of Single and Multiple Norfloxacin Resistance Mutations in Escherichia coli Implicated in Urinary Tract Infections. Antimicrob. Agents Chemother. 49: 2343-2351 [Abstract] [Full Text]  
  • Rafii, F., Park, M., Novak, J. S. (2005). Alterations in DNA Gyrase and Topoisomerase IV in Resistant Mutants of Clostridium perfringens Found after In Vitro Treatment with Fluoroquinolones. Antimicrob. Agents Chemother. 49: 488-492 [Abstract] [Full Text]  
  • Suda, N., Ito, Y., Imai, T., Kikumori, T., Kikuchi, A., Nishiyama, Y., Yoshida, S., Suzuki, M. (2004). The {alpha}4 residues of human DNA topoisomerase II{alpha} function in enzymatic activity and anticancer drug sensitivity. Nucleic Acids Res 32: 1767-1773 [Abstract] [Full Text]  
  • Komp Lindgren, P., Karlsson, A., Hughes, D. (2003). Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary Tract Infections. Antimicrob. Agents Chemother. 47: 3222-3232 [Abstract] [Full Text]  
  • Hurtle, W., Lindler, L., Fan, W., Shoemaker, D., Henchal, E., Norwood, D. (2003). Detection and Identification of Ciprofloxacin-Resistant Yersinia pestis by Denaturing High-Performance Liquid Chromatography. J. Clin. Microbiol. 41: 3273-3283 [Abstract] [Full Text]  
  • Ruiz, J. (2003). Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51: 1109-1117 [Abstract] [Full Text]  
  • Gross, C. H., Parsons, J. D., Grossman, T. H., Charifson, P. S., Bellon, S., Jernee, J., Dwyer, M., Chambers, S. P., Markland, W., Botfield, M., Raybuck, S. A. (2003). Active-Site Residues of Escherichia coli DNA Gyrase Required in Coupling ATP Hydrolysis to DNA Supercoiling and Amino Acid Substitutions Leading to Novobiocin Resistance. Antimicrob. Agents Chemother. 47: 1037-1046 [Abstract] [Full Text]  
  • Ince, D., Zhang, X., Silver, L. C., Hooper, D. C. (2003). Topoisomerase Targeting with and Resistance to Gemifloxacin in Staphylococcus aureus. Antimicrob. Agents Chemother. 47: 274-282 [Abstract] [Full Text]  
  • Ince, D., Zhang, X., Silver, L. C., Hooper, D. C. (2002). Dual Targeting of DNA Gyrase and Topoisomerase IV: Target Interactions of Garenoxacin (BMS-284756, T-3811ME), a New Desfluoroquinolone. Antimicrob. Agents Chemother. 46: 3370-3380 [Abstract] [Full Text]  
  • Pan, X.-S., Hamlyn, P. J., Talens-Visconti, R., Alovero, F. L., Manzo, R. H., Fisher, L. M. (2002). Small-Colony Mutants of Staphylococcus aureus Allow Selection of Gyrase-Mediated Resistance to Dual-Target Fluoroquinolones. Antimicrob. Agents Chemother. 46: 2498-2506 [Abstract] [Full Text]  
  • Valdezate, S., Vindel, A., Echeita, A., Baquero, F., Canto, R. (2002). Topoisomerase II and IV Quinolone Resistance-Determining Regions in Stenotrophomonas maltophilia Clinical Isolates with Different Levels of Quinolone Susceptibility. Antimicrob. Agents Chemother. 46: 665-671 [Abstract] [Full Text]  
  • Goni-Urriza, M., Arpin, C., Capdepuy, M., Dubois, V., Caumette, P., Quentin, C. (2002). Type II Topoisomerase Quinolone Resistance-Determining Regions of Aeromonas caviae, A. hydrophila, and A. sobria Complexes and Mutations Associated with Quinolone Resistance. Antimicrob. Agents Chemother. 46: 350-359 [Abstract] [Full Text]